Hikal informs about company updates

04 Nov 2019 Evaluate

Hikal has informed that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its API Unit located at Jigani, Bangalore for the inspection conducted in July 2019. The inspection resulted in one minor FDA Form 483 which was closed out immediately. 

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

208.65 -3.55 (-1.67%)
20-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1662.40
Dr. Reddys Lab 1164.45
Cipla 1386.10
Zydus Lifesciences 881.95
Lupin 2164.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×